德黑兰的“零日落差”:海湾盟友力挺特朗普的经济绞杀战

(SeaPRwire) -   By: Julian Holbrooke, an overseas international relations analyst who frequently contributes to major European daily newspapers美国驻联合国大使迈克·沃尔兹(Mike Waltz)在结束对巴林、阿联酋和英国的访问后表示,海湾盟友正全力支持特朗普政府对伊朗的封锁和经济施压行动。他透露,地区领导人普遍认为,德黑兰正切实体会到这种压力的痛苦。沃尔兹在周四晚间返回美国后不久接受采访时指出,局势瞬息万变,就在他离开该地区后不久,伊朗又对巴林发动了一次袭击。作为自战争爆发以来访问该地区最高级别的美国官员,沃尔兹强调,海湾伙伴国坚定支持本届政府通过封锁以及财政部长斯科特·万森特(Scott Bessent)的“经济狂怒行动”(Operation Economic Fury)来持续施压伊朗。他表示,盟友们通过多种方式向他展示了万森特经济战役对伊朗政权的实际影响。沃尔兹解释说,这一施压行动旨在挤压德黑兰,同时特朗普政府继续就防止伊朗获得核武器进行谈判。一位不愿透露姓名的美国官员在周五的吹风会上表示,预计未来几天将与伊朗签署一项协议,评估达成度为85%,但并非100%。尽管尚未完全抵达终点线,但双方已非常接近。沃尔兹特别提到,阿联酋方面坚信必须保持这种“可信的压力”,因为这是伊朗能够理解并作出回应的方式。沃尔兹表示,地区领导人证实了美国的评估,即伊朗经济在制裁、军事压力和孤立的多重打击下正在恶化。他指出,伊朗货币“暴跌”,外汇储备枯竭,通货膨胀持续上升,政权在支付军费、政府雇员和警察工资方面面临困难。他认为,伊朗政权将日益绝望,而特朗普政府的团队将利用这种压力为己方优势。在阿联酋,沃尔兹会见了总统穆罕默德·本·扎耶德(Sheikh Mohammed bin Zayed)和外交部长,他形容阿联酋是地区反对伊朗最活跃的伙伴之一。沃尔兹直言:“双方之间‘零日落差’(zero daylight)。”他还补充说,阿联酋“既有能力也有意愿”采取行动,并准备为阻止伊朗获得核武器这一长期目标承受“短期痛苦”。阿联酋在此次冲突中遭受重创,承受了“迄今为止最多的导弹、无人机和打击”,但已迅速恢复运作。沃尔兹还强调了《亚伯拉罕协议》在阿联酋立场中的重要作用,认为其与以色列日益增长的伙伴关系已成为地区对抗伊朗的“重要转变”。巴林也是沃尔兹此行的重要一站。该国是美国第五舰队的总部所在地,直接暴露在伊朗在霍尔木兹海峡附近的袭击和威胁之下。沃尔兹表示,只有亲身与他们交流,才能真正体会到他们是多么强大的盟友。他指出,美国和盟友团队在巴林正与全球航运公司、当地航运官员、保险公司及其他海事参与者合作,以确保全球最重要的能源通道之一——霍尔木兹海峡的航运畅通。沃尔兹指责伊朗做出“极其糟糕的决定”,攻击其邻国,包括酒店、港口设施和能源基础设施。在一次参观石油设施时,他发现证据表明伊朗在袭击储油罐前,故意瞄准了消防系统和一线救援人员,意图最大化破坏。他强调,伊朗“故意瞄准消防系统”,并且“首先故意攻击一线救援人员”。尽管遭受袭击,沃尔兹表示,盟友的防空系统在拦截伊朗导弹和无人机方面取得了“超过90%的成功率”,美军与海湾伙伴“紧密合作”。沃尔兹的行程最后抵达英国,他表示英国官员在联合国安理会就伊朗问题上一直是强有力的伙伴。他承认在基地和准入问题上存在“小插曲”和“颠簸”,但许多担忧已得到“平息”。他总结道,在“我们努力让伊朗在外交上孤立时,他们一直是非常好的合作对象”。Author bio: Julian Holbrooke, an overseas international relations analyst who frequently contributes to major European daily newspapers, offering sharp geopolitical insights and historical context to current global affairs.

Trump May Get His Signature, Tehran Gets the Narrative: The Real Winner of This Draft Deal Is Still Up for Debate

By: Marcus Sterling – SeaPRwire – Peace agreements are usually easiest to negotiate when both sides can claim victory. That appears to be exactly what is unfolding between Washington and Tehran. According to officials from both governments, a preliminary agreement to end the conflict could be signed within days. Yet the striking feature of the emerging deal is not the prospect of peace itself. It is the speed with which both capitals are presenting the same document as proof that they achieved their core objectives. The facts outlined by officials paint a complicated picture. U.S. representatives say the draft framework fulfills President Donald Trump’s primary goals and places future nuclear negotiations in a highly favorable position. Iranian Foreign Minister Abbas Araghchi is telling a very different story. He has publicly declared Iran the victor of the war and described the agreement as evidence that Tehran emerged stronger from the conflict. According to multiple sources familiar with the memorandum, the proposed arrangement would reopen the Strait of Hormuz, ease restrictions on Iranian oil exports, and begin the process of releasing frozen Iranian assets worth billions of dollars. In return, Iran would reopen the waterway and enter a sixty-day negotiation period focused on its nuclear program. U.S. officials maintain that any final agreement would require the dismantling of Iran’s nuclear program, the destruction and removal of its highly enriched uranium stockpiles, and a verification mechanism to enforce compliance. The strategic tension lies in what has not yet been resolved. Reports describing the draft suggest that several long-standing American demands may have been softened or postponed. Discussions about Iran’s missile program appear absent from the current framework. Questions surrounding war reparations remain open. Israel, which participated in military operations alongside the United States, is not a party to the negotiations. Prime Minister Benjamin Netanyahu has already indicated that Israel will not join the memorandum, while disagreements remain over future military activity in Lebanon. For Tehran, the immediate gains are tangible: potential sanctions relief, access to frozen assets, and the reopening of a maritime route that once carried roughly one-fifth of the world’s oil and gas supply. For Washington, the calculation appears centered on securing a pathway toward nuclear restrictions without prolonging a costly regional confrontation. Financial markets have already delivered their first verdict. Oil prices fell sharply, with Brent crude dropping more than three percent after news of the negotiations gained momentum. Investors are clearly pricing in reduced disruption risks across the Gulf region. Political markets may prove less predictable. Trump faces pressure from voters concerned about energy costs and from Republicans wary of appearing too accommodating toward Iran. Tehran must convince domestic audiences that it did not trade strategic leverage for economic relief. That is why the coming debate will not focus solely on what is written in the agreement. It will focus on who successfully defines the story surrounding it. In diplomacy, documents matter. Political narratives often matter more. Author bio: Marcus Sterling, a senior researcher at a European strategic affairs institute specializing in Middle East security, international negotiations, sanctions policy, and geopolitical risk analysis.

The AI Boom Has a Trust Problem, and ShelterZoom Is Betting That Data Provenance Will Be the Next Cybersecurity Battleground

By: Alex Mercer – SeaPRwire – Most companies are rushing to deploy AI. Far fewer can explain where their AI data came from, who touched it, whether it was altered, or how quickly they can recover when systems fail. That gap is becoming expensive. ShelterZoom’s latest partnerships with SB C&S, The Kenton Group, and Conscience IQ reveal a growing realization inside enterprise technology circles: the next phase of cybersecurity is no longer centered solely on preventing attacks. It is increasingly about proving trust, preserving operational continuity, and maintaining confidence in the data feeding AI systems. The official announcement highlights a broad international expansion strategy. Through partnerships with Japan-based SB C&S, U.K.-based The Kenton Group, and AI solution provider Conscience IQ, ShelterZoom is extending the reach of three flagship products across North America, Europe, Asia-Pacific, and the Middle East. The first is Mithra AI, designed to provide verified context, data lineage, governance, and a trusted single source of truth for enterprise AI systems. The second is Document GPS, a document tokenization platform that replaces traditional file sharing with secure document tokens while allowing originators to track access, downloads, screenshots, sharing activity, and document interactions even after distribution. The third is Spare Tire, a cyber and operational resilience platform built to maintain business continuity and prevent downtime, particularly within healthcare environments where electronic health record disruptions can directly affect patient care. The deeper message sits beneath the product descriptions. Enterprises are discovering that AI readiness is increasingly tied to data credibility. ShelterZoom references findings from Fivetran’s 2026 Agentic AI Readiness Index, which identified data quality and lineage, regulatory compliance, sovereignty requirements, privacy concerns, and interoperability challenges as major obstacles to enterprise AI adoption. According to the cited research, 86% of data leaders view interoperability as essential for AI success. In practical terms, organizations are beginning to realize that sophisticated AI models offer limited value if the underlying data cannot be verified. At the same time, healthcare providers face mounting operational risks from ransomware attacks, system outages, and pending regulatory requirements such as HIPAA’s proposed 72-hour restoration rule. Spare Tire is being positioned as a response to that pressure, offering continuous operational capability and synchronized recovery rather than traditional disaster-recovery approaches that activate only after failure occurs. The competitive landscape may look very different over the next several years. Traditional cybersecurity vendors built their businesses around detection, response, and recovery. A new category is emerging around trust verification, data lineage, operational continuity, and AI integrity. ShelterZoom appears determined to claim territory in that category before larger competitors fully mobilize. Whether the company succeeds will depend on execution, distribution reach, and customer adoption. One thing already seems clear: in the AI era, organizations will not be judged solely by how well they protect data. They will also be judged by how convincingly they can prove that the data can be trusted. Author bio: Alex Mercer, a veteran technology analyst and former enterprise systems architect who focuses on cybersecurity, artificial intelligence infrastructure, digital trust frameworks, and emerging enterprise technology markets.

Why a TV Show About Small-Cap Stocks Now Looks More Like a Curated Capital Marketplace Than a Traditional Business Program

By: Christian Brooks – SeaPRwire – The hardest problem for emerging public companies is not building a product. It is getting noticed. Every week, hundreds of small and mid-sized firms compete for investor attention. Most never break through. That reality explains why New to The Street continues to occupy an unusual position in the capital markets. On the surface, tonight’s Bloomberg Television broadcast is another business program. Look closer and it resembles something far more strategic: a media-driven marketplace where companies compete for visibility, credibility, and investor mindshare. The official announcement focuses on the companies appearing in tonight’s 6:30 PM ET broadcast across the United States, Latin America, and the MENA region. The lineup spans a remarkably broad range of industries. Envoy Medical discusses hearing restoration technologies. Big Sky Industrial outlines its helium production strategy, carbon management infrastructure initiatives, and the development of the Big Sky Carbon Hub in Montana. Graphene Manufacturing Group presents advances in graphene production and energy storage technologies. Gold Royalty Corp. provides updates on its growing portfolio of precious-metals royalty interests. BlackBarn Restaurant shares its experience operating in New York City’s highly competitive hospitality market. Additional sponsored segments feature Data Vault Holdings, Lantern Pharma, Medicus Pharma, Roadzen, and FreeCast, exposing viewers to companies active in artificial intelligence, biotechnology, healthcare, insurance technology, and digital media. The deeper story sits behind the guest list. New to The Street is not merely selling airtime. It is selling distribution. According to the company, its business media network now extends across Bloomberg Television, FOX Business, outdoor advertising campaigns, social platforms, digital marketing channels, and two rapidly growing YouTube properties. The flagship New to The Street TV channel has surpassed 4.76 million subscribers, while NewsOut has exceeded 880,000 subscribers. Together, the platforms reach more than 5.7 million subscribers. For many emerging companies, access to that audience may be as valuable as access to traditional investor conferences. In today’s market, visibility often functions as a form of currency. A company that cannot attract attention frequently struggles to attract capital. From an investor’s perspective, the program also reflects a larger shift taking place in financial media. Sector boundaries continue to blur. A single broadcast can move from hearing technology to helium infrastructure, from graphene-based energy innovation to gold royalties, then into artificial intelligence and digital media. Investors are no longer consuming information through narrow industry channels. They are hunting for opportunities wherever growth narratives emerge. That makes platforms like New to The Street less of a television show and more of a discovery engine. The winners will not necessarily be the companies with the most airtime. They will be the firms that can convert visibility into execution, because exposure opens the door, but results keep it open. Author bio: Christian Brooks, a veteran entrepreneur and investor with decades of experience evaluating growth-stage businesses, capital formation strategies, and the evolving relationship between media exposure and market performance.

The Real Battle Isn’t on the Pitch: Why Someone Just Built a Database for Every Controversial Referee Call in Soccer

By: James Vance – SeaPRwire – Most soccer arguments die within 48 hours. Fans rage online, television panels replay a controversial decision, and then the conversation moves on to the next match. That cycle is exactly what NotFair.com is trying to break. The newly launched platform is built around a simple idea: instead of debating referee decisions as isolated incidents, collect them, organize them, and study them as data. At a time when global attention is building toward the 2026 FIFA World Cup, the project taps into one of soccer’s most emotional pressure points—whether officiating can ever be examined objectively. According to the company’s announcement, NotFair.com allows supporters to report referee decisions from matches around the world, track those decisions across competitions and seasons, and analyze information submitted by the community. The platform was founded by Hakan Ugdur, who argues that discussions around officiating become more meaningful when they are documented in a structured format rather than scattered across social media posts and post-match debates. The site does not label decisions as right or wrong. Instead, it acts as a repository where fans can contribute observations and explore aggregated trends. The stated goal is transparency through organized information rather than verdicts. The more interesting question is what happens if enough fans actually participate. Soccer has no shortage of opinions. What it lacks is a historical record that ordinary supporters can easily search and compare. A controversial penalty in one league often disappears from public memory within weeks. A disputed red card in another competition rarely becomes part of a larger conversation. By building a database of referee decisions and match incidents, NotFair.com is attempting to turn emotional reactions into a searchable body of evidence. Whether the data ultimately proves anything is secondary. The act of collecting it may be the platform’s biggest contribution. The commercial logic is straightforward. Data tends to become more valuable as it accumulates. If NotFair.com succeeds in creating a comprehensive archive of officiating decisions across global soccer, it could become a reference point for fans, analysts, media commentators, and researchers interested in refereeing trends. The challenge is less about technology and more about participation. Every community-driven platform depends on sustained user contributions. If soccer supporters embrace the idea, referee debates may finally move beyond clips and complaints. If they do not, the platform risks becoming just another forgotten corner of the internet. For now, the outcome depends less on referees and more on whether fans are willing to become data collectors. Author bio: James Vance, a veteran international technology and business commentator who specializes in analyzing how data platforms reshape public discussion, digital communities, and emerging online markets.

Chow Tai Fook Jewellery Reports Record High Profit Brand Transformation Delivering High-quality Earnings Growth

Results Highlights Chow Tai Fook Jewellery delivered strong FY2026 performance on the back of successful brand transformation, achieving high-quality earnings growth against macro uncertainties and significant gold price volatility. Revenue grew 5.3% to HK$94,398 million, underpinned by steady growth from design-led and higher-margin iconic collections. The Group achieved an operating profit of HK$18,850 million (+27.8% YoY) and a record high profit attributable to shareholders of HK$9,004 million (+52.2% YoY). Gross profit margin expanded to 32.3%, supported by higher gold prices and increased contribution from the retail business and design-led jewellery. Operating profit margin expanded 360bps to a five-year high level of 20.0% driven by strong business performance and continued disciplined cost management. Return on Equity (“ROE”) increased to 28.4%, which represented a sustained improvement against our 5-year historical average of 20.5%. The Group opened its first global flagship store in Hong Kong in February 2026, alongside newly designed stores across the Chinese Mainland and key international markets, while expanding into luxury lifestyle categories. The Board has proposed a final dividend of HK$0.45 per share, bringing the full-year total to HK$0.67 per share, a payout ratio of 73.4%, reflecting our commitment to sustained shareholder returns. Financial Summary   For the year ended 31 March 2026 HK$ million 2025 HK$ million YoY Change Revenue 94,398 89,656 +5.3% Gross profit 30,500 26,455 +15.3% Gross profit margin 32.3% 29.5% +280 bps Operating profit(1) 18,850 14,746 +27.8% Operating profit margin 20.0% 16.4% +360 bps Profit attributable to shareholders of the Company 9,004 5,916 +52.2% Earnings per share       Basic (HK$) 0.91 0.59 +53.7% Diluted (HK$) 0.90 0.59 +52.5% Full year dividend per share(2) (HK$) 0.67 0.52 N/A   (1)  Aggregate of gross profit and other income, less selling and distribution costs and general and administrative expenses (2)  The payout ratio for FY2026 approximated 73.4% (Hong Kong, China, 11 June 2026) Chow Tai Fook Jewellery Group Limited (“Chow Tai Fook Jewellery Group”, the “Group” or the “Company”; SEHK stock code: 1929), today announces its annual results for the year ended 31 March 2026 (“FY2026”). Record Results Underscore the Continued Success of Brand Transformation The Group demonstrated strong resilience as revenue grew 5.3% to HK$94,398 million in a year marked by macroeconomic uncertainty and significant gold price volatility. Gross profit margin of 32.3% was up 280bps, driven by the surge in gold price and a higher contribution from the design-led and higher- margin iconic collections, successfully launched since 2024. Operating profit grew 27.8% to HK$18,850 million and profit attributable to shareholders grew 52.2% to a record high HK$9,004 million. Operating profit margin of 20.0% was up 360 bps to a five-year high level. The Group’s Return on Equity (“ROE”) increased to 28.4%, which represented a sustained improvement against our 5-year historical average of 20.5%. The Board has proposed a final dividend of HK$0.45 per share, bringing the dividend per share for the year to HK$0.67, a full-year payout ratio of 73.4%.  The strong performance was powered by a customer centric approach driven by three key levers of growth: (1) Redefining Chinese luxury globally, (2) Rejuvenating portfolio and operational efficiency and (3) Reimagining new horizons. Dr. Henry Cheng, Chairman of Chow Tai Fook Jewellery Group, said, “We are committed to investing boldly in our brand – elevating desirability, forging deeper emotional connection with customers, and expanding our global resonance through immersive retail experience, exquisite craftsmanship, compelling storytelling and digital engagement that blends our rich heritage and cultural artistry with contemporary lifestyle.” Commenting on the annual results, Ms. Sonia Cheng, Vice-chairman of Chow Tai Fook Jewellery Group, said, “We are delighted that the Group achieved record high results and high-quality earnings, validating the success of our brand transformation. As a leading global Chinese luxury group, Chow Tai Fook is charting a course to bring Chinese aesthetics, craftsmanship, and heritage storytelling to the world stage while setting a new benchmark for the industry. Redefining Chinese Luxury Globally The global luxury landscape has been dominated by Western culture. Our ambition is to redefine Chinese luxury globally, showcasing the contemporary Chinese culture, innovation and exquisite craftsmanship to the world. The successful launch of our signature collection – DAWN Collection, has clearly demonstrated Chow Tai Fook’s innovation and creativity, being the first jewellery brand to blend Chinese aesthetics with modern craftsmanship. Since its launch in April 2026 till the end of May 2026, DAWN Collection has delivered remarkable initial results, with Retail Sales Value (“RSV”) of over HK$500 million, outperforming the debut of some of the signature collections to date. Furthermore, more than 20% of customers purchasing this Collection were new to us in the Chinese Mainland, Hong Kong and Macao, underscoring the effectiveness of our signature collections in driving new customer acquisition. During the year, we unveiled our first High Jewellery Collection, “Timeless Harmony”, championing Eastern aesthetics through culturally rooted, world‑class craftsmanship and expanding the brand’s presence in the global high jewellery segment. In March 2026, we appointed David Tse as Global Creative Director, bringing deep luxury expertise from his tenure as Creative Director at Hermès in China, to lead our global storytelling and deepen brand desirability. Blending heritage with contemporary designs, our signature collections continue to resonate with the growing base of culturally conscious consumers. The Rouge Collection, Joie Collection and Chow Tai Fook Palace Museum Collection sustained strong sales momentum in FY2026, contributing close to HK$10 billion to our RSV, while the iconic HUÁ Collection contributed HK$43 billion to our RSV. Rejuvenating Portfolio and Operational Efficiency In February 2026, the Group opened its first global flagship store on Canton Road in Tsim Sha Tsui, Hong Kong, marking a significant milestone in its brand transformation journey. The approximately 10,000-square-foot flagship is the Group’s largest store across Hong Kong and Macao, showcasing the brand’s nearly century-long legacy, craftsmanship and creativity through it’s “Heritage Pavilion” and diverse offerings. The flagship offers consumers an elevated retail experience that reflects our evolving ambition as the leading global Chinese luxury group. As of FY2026, we had a total of 8 newly designed luxury-format stores in prime locations in the Mainland. These stores delivered significantly higher productivity, which was approximately 8 to 10 times the average Same Store Sales (“SSS”). These newly designed stores also had a substantially higher contribution from fixed-price jewellery. We also selectively opened stores in high-footfall locations, backed by enhanced visual merchandising, optimised product mix and elevated retail experience. As a result, the average monthly RSV of new stores aged less than two years reached approximately HK$1.6 million, up 57% YoY. In view of the success of the newly designed luxury-format stores, we plan to expand its network in the Mainland from the current 8 stores to 50 by FY2030. In the Mainland, SSS increased by 6.9% in FY2026, supported by our ongoing brand transformation initiatives and continued store optimisation. In Hong Kong and Macao, consumer demand strengthened notably post Mainland VAT reform on gold trading, with SSS rising 16.8% in FY2026. SSS growth in Hong Kong was 13.3% and Macao was 29.4% for the year. During the year, the Group also advanced digitalisation and launched our in-house AI Agent platform, deploying over 12 agents across functions such as visual merchandising, the GenAI jewellery creative centre, and AI live streaming, to drive operational efficiency and enhance customer engagement. Reimagining New Horizons The Group’s FY2030 ambition is to double the RSV of our international operations compared to FY2026; and to have an international footprint of over 100 stores. In line with our ambition, the Group expanded the Chow Tai Fook universe into new geographies, channels, product categories, and experiences that resonate with the constantly evolving lifestyle and aspirations of customers in FY2026. With the ambition to reshape global luxury and further strengthen our brand influence among global audiences, newly designed luxury-format stores were launched at Jewel Changi Airport in Singapore, Siam Paragon in Bangkok, and Westfield Sydney in Australia – marking our first entry into Oceania. This brings the total number of CHOW TAI FOOK JEWELLERY POS in Other Markets to 63. In FY2027, we will open further newly designed luxury-format stores across Southeast Asia and North America, while exploring opportunities in the Middle East in the next two years. As the first global Chinese jewellery brand to enter the luxury lifestyle arena, the new luxury home-décor line “Chow Tai Fook Home” brings craftsmanship, cultural heritage and attention to detail to refined home décor and functional art, including tableware collections developed in collaboration with renowned French porcelain house Bernardaud, where Western craftsmanship meets Chinese cultural heritage and gold artistry. Together with CTF Accessories which covers hair adornments, gold medallions and watch strap accessories, the new lifestyle offers will capture diverse market segments, broaden our customer base and create synergies with our core jewellery business. In FY2026, we continued to collaborate proactively with renowned IPs to reach new audiences. Our Black Myth Collection received overwhelming market response, with a significantly higher male mix than the Group average. Meanwhile, collaborations with Disney, Chiikawa and the NBA attracted new loyalty members, which accounted for 35%–55% of these IP collaborations’ customers, with a significant percentage of younger generations. HEARTS ON FIRE, a member of the Group, has continued its transformation into a modern global luxury diamond jewellery brand within the Group. During the year, HEARTS ON FIRE delivered resilient performance with its iconic INSIDE/OUT Collection contributing to 13% of the brand’s global revenue. The brand also expanded its retail presence in Asia with five new luxury retail locations, strengthening visibility in key luxury markets. Business Outlook The strong financial and operational performance highlights the success of our brand transformation strategy and paves the way for further growth. We are now entering the definitive phase of our multi-year transformation journey to our centenary in 2029, accelerating the pace and ensuring the precision of our full-scale strategic execution in FY2027 and beyond. Our sharpened focus is on elevating brand desirability, enriching the retail experience, and strengthening product differentiation. Despite continuing external market volatility and macroeconomic uncertainty, we remain cautiously optimistic in the markets where we operate. We are firmly committed to our brand transformation journey – redefining Chinese luxury globally, rejuvenating portfolio and operational efficiency and reimagining new horizons. We will continue to rigorously uphold financial discipline in cost and capital management, driving high-quality growth, sustainable earnings and returns for our shareholders. FY2030 Ambitions As we approach our centenary, we envision a Chow Tai Fook universe where jewellery seamlessly intertwines with the lifestyle of our customers – enriching their appreciation of cultural heritage, artistry, and craftsmanship. We see luxury as a universal language that transcends borders and cultures, where jewellery and lifestyle come together to express a shared vision of beauty, elegance, and creativity. Looking ahead to FY2030, we have set out the following ambitious targets: Financial performance: We aim to achieve above-market revenue growth, and sustain a high ROE of above 25% by FY2030; Store network evolution: We target to complete the full renovation and elevation of our POS portfolio by FY2030, delivering a cohesive and distinctive retail experience across all locations. In parallel, we plan to expand our network of newly designed luxury-format stores in the Mainland from the current 8 stores to 50 by FY2030; International expansion: We aim to double the RSV of our international operations compared to FY2026; and to have an international footprint of over 100 stores. Sustainability: We will target a 50% reduction in Greenhouse Gas emissions by FY2030, using FY2024, the first year of our brand transformation journey, as the base year. Chow Tai Fook Jewellery Group Limited Since its founding in 1929, CHOW TAI FOOK, the flagship brand of Chow Tai Fook Jewellery Group, has been celebrated for its bold designs and meticulous attention to detail. Our commitment to innovation and craftsmanship has made us synonymous with excellence, value, and authenticity. As the global Chinese luxury group, we blend contemporary designs with traditional techniques to create timeless pieces. Each collection reflects our customers’ stories and lives, celebrating their special moments. We aspire to inspire and captivate generations to come, weaving the story of CHOW TAI FOOK into their own. Our brand portfolio includes the iconic CHOW TAI FOOK flagship brand, HEARTS ON FIRE, ENZO, and MONOLOGUE, offering a wide variety of products that also includes an expanding range of cutting-edge IP collaborations. With over 5,000 stores worldwide, we offer a seamless client journey across all touchpoints that includes a network across China as well as a growing number of global locations. Chow Tai Fook Jewellery Group Limited (SEHK: 1929) has been listed on the Main Board of the Hong Kong Stock Exchange since December 2011. We are committed to delivering sustainable long-term value for our stakeholders by continually enhancing earnings quality and driving higher value growth.   Media Enquiries: Chow Tai Fook Jewellery Group Limited Haide Ng Associate Director, Corporate Communications Tel: (852) 3115 4402 Email: haideng@chowtaifook.com 11/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News. The issuer is solely responsible for the content of this announcement. Media archive at www.todayir.com

WHAT WATON’S NEW PLATFORM – MoTA IS DESIGNED TO HELP USERS DO

EQS Newswire / 09/06/2026 / 16:00 UTC+8 (9 June 2026, Hong Kong) Waton Financial Limited Unveils MoTA: An AI-Native Investment Team Operating System and Agent Marketplace That Lets Anyone Build, Manage, and Command Their Own Professional Investment Research Team Waton Financial Limited today unveiled MoTA (Manager of Trading Agents), an AI-native investment team operating system and Agent marketplace that redefines what AI can do for investors. MoTA is not a stock-picking chatbot or a black-box trading bot. It is a platform designed to let users build, manage, and command their own team of specialized AI Agents across the full investment workflow — from portfolio definition to trade execution. The Problem Professional investment research has always required a team: factor researchers, fundamental analysts, technical analysts, risk managers, portfolio constructors, and trade execution officers. Each role demands specialized talent and expensive infrastructure. For individual investors and small teams, assembling such a capability has been cost-prohibitive — until now. The Solution MoTA transforms the user from a passive consumer of AI signals into an active leader of an AI-powered investment team. Its four integrated modules work together to deliver a seamless, end-to-end experience. First, Talents — the Agent Marketplace. Users browse, compare, and hire specialized AI Agents by role. Each Agent is purpose-built for a specific investment function — fundamental analysis, technical analysis, risk management, trade execution, and more. Agents can be swapped and composed as strategies evolve. Second, Team — composing your investment team. Users assemble multiple Agents into a structured team. Analysts feed research inputs, the Portfolio Manager evaluates and writes memos, the Risk Manager reviews exposure, and the Trader validates routing. The human user retains final sign-off authority at every stage. Third, Portfolio — the portfolio cockpit. A real-time overview of holdings, assets, P&L, risk, and exposure. Users see exactly what is moving across positions, where risk sits, and where returns originate — all in one unified view. Fourth, Decision — the Decision Center. Every Agent-generated suggestion surfaces in the Decision Center with full context: source Agent, signal, reasoning, and current status. Users can click into the full workflow or execution path, compare competing analyses, and manage an actionable queue of decisions. Every recommendation is structured, traceable, and auditable. These four modules connect in a continuous workflow: Portfolio to Decision to Team to Trade. Why MoTA Is Different Traditional AI investing tools offer a single AI chat box, scattered research answers, black-box signals, no role separation, and AI value that is hard to measure. Reviews are tied to AI silos. MoTA provides a multi-Agent investment team, a connected Portfolio-to-Trade workflow, an auditable Decision Center, dedicated Analyst and PM and Risk and Trader roles in coordination, unified metrics such as ROI and win rate and cost per run and override rate, and a unified path for portfolio, decisions, Agents, and trades. The Vision Behind MoTA Waton Financial Limited's mission with MoTA is clear: to make professional-grade multi-agent investing tools more accessible, more transparent, and more user-controlled. MoTA does not replace human judgment — it amplifies it. The platform frees users from the burden of being a full-stack investment expert and elevates them to a higher role: the builder, manager, and decision-maker of their own AI investment team. As AI moves from content generation into workflow execution, investing — inherently a multi-role, multi-step, multi-constraint process — is a natural fit for this transformation. MoTA is designed to bridge the gap between what AI can do and what the investment workflow actually needs. About MoTA MoTA (Manager of Trading Agents) is Waton Financial Limited's flagship AI-native investment team operating system and marketplace for specialized investing Agents. It enables users to create fully customizable investment teams, assign specialized AI Agents to each role, and receive structured, traceable, and auditable investment suggestions across the entire Portfolio-to-Trade workflow. About Waton Financial Limited Waton Financial Limited is a publicly listed financial services and technology company that designs, owns, and operates the MoTA platform. Waton is committed to building AI-native infrastructure for investment teams and making professional-grade multi-agent investing tools accessible to a broader audience. Welcome to MoTA. Welcome to the new era of investing.   Media Contact Email: ir@watonfinancial.com Website: https://wtf.us Explore MoTA: https://mota.ai   Disclaimer: This press release contains forward-looking statements. Actual results may differ materially from those expressed or implied. This is not investment advice. Past performance does not guarantee future results. 09/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News. The issuer is solely responsible for the content of this announcement. Media archive at www.todayir.com View original content: EQS News

Hitachi Energy expands zero-emission power portfolio with HyFlex Compact

LONDON, June 12, 2026 - (JCN Newswire via SeaPRwire.com) - Hitachi Energy, a global leader in electrification, has introduced HyFlex® Compact - a hybrid generator and flexible power hub that provides zero-emission electricity for temporary and off-grid applications such as construction projects and other infrastructure. The configurable system combines hydrogen fuel cells with high-performance batteries and can integrate additional power sources, delivering stable AC power as a clean alternative to diesel generation.As electricity demand rises, companies across industry and infrastructure are electrifying operations and cutting emissions, often in locations where grid connections are limited or unavailable. This is increasing demand for flexible power solutions that can perform reliably acrossa wide range of operating conditions, from remote sites to grid-connected environments.Addressing these requirements calls for power solutions that go beyond single technologies, supported by robust system expertise and integration capabilities. Designed for standalone orgrid-connected operation, Hitachi Energy’s HyFlex Compact combines hydrogen fuel cells, batteries, power electronics, cooling, and auxiliaries in a single, portable enclosure, all managed by an optimized control system. The system converts hydrogen into clean electricity using fuel cells, producing power, heat, and water with no harmful emissions.With optional AC and DC input modules, Hyflex Compact can operate as a mobile microgrid, connecting multiple energy assets, providing stable AC power whenever and wherever it is needed. This enables more efficient operation and reduces reliance on hydrogen when additional power sources are available.“The energy system is being asked to deliver more electricity, with lower emissions and higher resilience, often in places where the grid was never designed for today’s demands,” said Marco Berardi, Head of Grid & Power Quality Solutions and Service at Hitachi Energy. “HyFlex Compact brings together different technologies through system integration expertise to support a secure electricity supply as energy systems evolve, while helping companies move toward lower emission power.”HyFlex Compact is suitable for applications across a wide range of operating environments, from construction sites and temporary infrastructure such as events and festivals to electric vehicle charging, mining operations, remote industrial sites, critical infrastructure, and hard-to-abate operating environments.The introduction of the flexible power hub marks an evolutionary step, building on Hitachi Energy’s earlier HyFlex developments. Initial pilots explored hydrogen-to-power applications and provided valuable insight into integrating fuel cells, power electronics, and control systems in real-world operating environments1.Hitachi Energy continues to bring flexible, low-emission solutions to market, underpinned by its expertise in power electronics and system integration. Recent investments in power electronics capabilities, including the inauguration of the Grid & Power Quality Solutions and Service Test Center in Västerås, Sweden, and the announcement of a new Power Electronics Center of Competence in the United States*1, underscore the company’s focus on strengthening the technologies needed to support secure, affordable, sustainable and resilient electricity systems.*1 Hitachi Energy expands its U.S. footprint with $10 million USD investment in North Carolina to meet surging electricity demandSome of HyFlex pilot projectsHitachi Energy and Air Products pioneer zero-emission construction site in the NetherlandsHitachi Energy’s pioneers HyFlex hydrogen-powered generator with shore power system for ships at berthHitachi Energy enables decarbonization of construction site in SwedenAbout Hitachi EnergyHitachi Energy is a global leader in electrification, powering the electricity era to meet the energy demands of today, and the next 25 years. As the energy arm of Hitachi Group, over three billion people depend on our pioneering, mission critical technologies to power their daily lives. With over a century of innovation, we are addressing the most urgent energy challenge of our time: driving the evolution of the world’s energy system to ensure abundant, secure, affordable, and sustainable power for today’s generation and the next. With an unparalleled installed base in over 140 countries, we are the grid ecosystem partner across the utility, industry, data center, and transportation sectors. Headquartered in Switzerland, we employ over 56,000 people in 60 countries and generate revenues of around $20 billion USD.Https://www.hitachienergy.comhttps://www.linkedin.com/company/hitachienergyhttps://x.com/HitachiEnergy About Hitachi, Ltd.Through its Social Innovation Business (SIB) that brings together IT, OT(Operational Technology) and products, Hitachi aims to be a global leader in continuously transforming social infrastructure through digital, contributing to a harmonized society where the environment, wellbeing, and economic growth are in balance. Hitachi operates worldwide across four sectors - Digital Systems & Services, Energy, Mobility, and Connective Industries - as well as a Strategic SIB Business Unit focused on new growth areas. With Lumada at its core, Hitachi creates value by combining data, technology and domain knowledge to solve customer and social challenges. Revenues for FY2025 (ended March 31, 2026) totaled 10,586.7 billion yen, with 606 consolidated subsidiaries and approximately 290,000 employees worldwide. Visit us at www.hitachi.com.   Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

Hitachi Energy unveils AxoniQ: game-changing solution for the next era of transmission grids

LONDON, June 12, 2026 - (JCN Newswire via SeaPRwire.com) - Hitachi Energy, a global leader in electrification, today announced the launch of AxoniQ™, its comprehensive portfolio of solutions for multi-terminal direct current(MTDC) systems. As global electricity demand accelerates, MTDC systems are becoming critical to ensuring a secure, affordable, and sustainable power grid. As renewable energy deployment accelerates and power systems become increasingly interconnected, MTDC systems help manage congestion and improve resilience by allowing dynamic power flow between multiple terminals and across different energy markets, while supporting faster planning, procurement, and execution of grid projects. By connecting multiple power sources and demand points, MTDC grids enable electricity to be directed where it is needed most.ENTSO E’s Offshore Network Development Plans 2024 report*1 highlights that by 2040, Europe is moving into a massive scale-up phase of offshore renewables, which requires major transmission expansion and early hybrid grids. Grids developed with MTDC systems can boost transmission capacity up to nearly threefold in a 2040 scenario.*1 Offshore Network Development Plans European offshore network transmission infrastructure needsAchieving the same capacity and reliability without these solutions would require substantial capital investment. Optimized assets not only translate into fewer converter stations, but also into fewer power cables and lines and a reduced use of land and materials, underpinning a more sustainable energy system for the benefit of both society and the environment.Marking a significant step toward greater interoperability, the launch of AxoniQ comes as governments and grid operators worldwide accelerate investments in transmission infrastructure toward a fully electrified world to integrate renewable energy at scale, strengthen cross-border interconnections, and improve energy security.The AxoniQ portfolio combines advanced power electronics and control technologies. It includes:AxoniQ Protect: An innovative solution that can interrupt a DC fault in less than three milliseconds, it offers fast and effective protection at up to 525 kilovolts (kV). It enables selective fault isolation by disconnecting only the affected section of the DC grid, while the rest of the system continues operating. This continuous, proactive protection enables extremely low losses and the optimal combination of performance, efficiency, and reliability throughout the entire lifecycle.AxoniQ Connect: A modular DC switching station that enables the connection of new terminals and structures the grid into several protection zones, creating manageable subsystems. AxoniQ Connect ensures reliable service continuity, simplifies maintenance, and supports cost-efficient scalability.AxoniQ Control: An advanced control system built with interoperability in mind that maintains voltage stability and power balance, optimized power flow, and flexible, market-driven energy exchange. AxoniQ Control addresses congestion and enables quick reconfigurations in the event of disturbances.Together, the AxoniQ suite of cutting-edge power electronics solutions enables the re-routing of power in real time, rapid fault isolation, and maintaining continuity of power supply while minimizing the impact on the wider grid and avoiding the risk of costly power interruptions. Engineered for interoperability by design, AxoniQ will continue to evolve to enable a sustainable expansion of direct current (DC) grids in the decades ahead.“Electricity networks are becoming increasingly complex as renewable generation grows and demand patterns evolve. AxoniQ represents a milestone in the evolution of DC grids, enabling the next generation of HVDC systems, helping grid operators integrate renewable power more reliably and affordably while improving grid resilience and transmission efficiency,” said Niklas Persson, CEO, Grid Integration Business Unit at Hitachi Energy. “Hitachi Energy is pioneering the new technology needed today and helping ensure future prosperity.”The AxoniQ family is part of Hitachi Energy’s Grid-enSure®, a fully integrated solution portfolio to stabilize power systems by strengthening transmission, managing frequency variations and system voltage and addressing capacity constraints. AxoniQ takes its name from axons, the part of a nerve cell (neuron) that carries electrical signals away from the cell body to other neurons, muscles or glands, effectively functioning as the body’s electrical system. Like axons, AxoniQ brings power to life across the grid – intelligently and effectively transmitting electricity between multiple sources and demand points, acting as the vital connection that enables amore responsive, resilient, and interconnected energy system.AxoniQ has been researched and developed by Hitachi Energy for more than a decade, and its benefits are demonstrated through the company’s work in partnership with TSOs and main industry players with the aim of making future HVDC systems mutually compatible and interoperable by design.About Hitachi EnergyHitachi Energy is a global leader in electrification, powering the electricity era to meet the energy demands of today, and the next 25 years. As the energy arm of Hitachi Group, over three billion people depend on our pioneering, mission critical technologies to power their daily lives. With over a century of innovation, we are addressing the most urgent energy challenge of our time: driving the evolution of the world’s energy system to ensure abundant, secure, affordable, and sustainable power for today’s generation and the next. With an unparalleled installed base in over 140 countries, we are the grid ecosystem partner across the utility, industry, data center, and transportation sectors. Headquartered in Switzerland, we employ over 56,000 people in 60 countries and generate revenues of around $20 billion USD.Https://www.hitachienergy.comhttps://www.linkedin.com/company/hitachienergyhttps://x.com/HitachiEnergyAbout Hitachi, Ltd.Through its Social Innovation Business (SIB) that brings together IT, OT (Operational Technology) and products, Hitachi aims to be a global leader in continuously transforming social infrastructure through digital, contributing to a harmonized society where the environment, wellbeing, and economic growth are in balance. Hitachi operates worldwide across four sectors – Digital Systems & Services, Energy, Mobility, and Connective Industries – as well as a Strategic SIB Business Unit focused on new growth areas. With Lumada at its core, Hitachi creates value by combining data, technology and domain knowledge to solve customer and social challenges. Revenues for FY2025 (ended March 31, 2026) totaled 10,586.7 billion yen, with 606 consolidated subsidiaries and approximately 290,000 employees worldwide. Visit us at www.hitachi.com.  Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

红海局势紧张!专家预警胡塞行动或致全面升级

(SeaPRwire) -By: Douglas Vance US hits back at Houthi threats to block Red Sea waterway. Houthi declared ban on Israeli ships in Red Sea. Red Sea is key oil route. State Dept slams Houthi actions. Expert Fitton-Brown says Houthi tactics may not work. Ethiopia, populous, steps in as US ally against terror. Ethiopia has ties with Iran. No response from War Dept or Ethiopian govt yet. Author bio: Douglas Vance, maritime defense scholar and naval intelligence briefing coordinator

Team Mitsubishi Ralliart Confirms Triton Readiness as It Targets Second Consecutive AXCR Title

TOKYO, June 12, 2026 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Motors Corporation (hereafter, Mitsubishi Motors) announced that Team Mitsubishi Ralliart, which receives technical support from the company, successfully completed a seven-day endurance test in mid-May on off-road courses near Khao Yai National Park in northeastern Thailand. Under conditions simulating the Asia Cross Country Rally (AXCR), the test confirmed the intended performance of the improvements made to the Triton. Team Mitsubishi Ralliart will enter three Triton pickup trucks in AXCR 2026 in Thailand this August, as it aims for a second consecutive title.AXCR 2026 will cover approximately 2,000 kilometers across six days in the hot, humid climate and demanding terrain typical of Southeast Asia. The course features steep mountainous terrain, narrow and rugged jungle trails, low- to medium-speed rough roads with muddy tracks and river crossings caused by sudden downpours, as well as relatively flat, high-speed unpaved sections such as grasslands and farm tracks.Aiming to secure back-to-back victories, Team Mitsubishi Ralliart has further unlocked Triton’s potential and improved its dynamic performance so that drivers can tackle AXCR’s highly varied and severe conditions with greater control. With adjustments to the vehicle layout, including the powertrain position, the team improved front-to-rear weight distribution. The suspension was also fine-tuned to increase tire contact at all four wheels, improving steering stability and cornering performance. In addition, engine response in the low- to mid-speed range has been refined to improve drivability and off-road capability."The AXCR, where vehicles must run at high speed over a diverse and grueling course, the load imposed on the vehicle body by road impact is said to be, in some cases, more than thirty times greater than in normal customer driving," said Hiroshi Masuoka, team director of Team Mitsubishi Ralliart. "The technical information gained through our participation in the AXCR over the past four years has not only improved the competitiveness of our rally cars, but has also provided valuable insight for strengthening the appeal of our production vehicles. These learnings have been applied not only to the Triton, but also to the all-new Pajero, which will make its world premiere this autumn. Through vehicle development honed through rally activities, Mitsubishi Motors will continue to deliver distinctive and compelling products that reflect Mitsubishi Motors’ identity."Team Mitsubishi RalliartTeam Director: Hiroshi Masuoka (Mitsubishi Motors)Team Principal: Chayut Yangpichit (Tant Sport)Technical Director: Kopong Amatayakul (Tant Sport)Drivers and Co-drivers:Driver: Chayaphon YothaFrom: Udon Thani Province, ThailandBorn: August 16, 1987 (38)Career: Actively participating in numerous rallies and races in Thailand. Two time AXCR overall champion (2022, 2025). Known for precise, careful driving style and ability to maintain high speed without damaging the vehicle.Co-driver: Peerapong Sombutwong (Thailand) Driver: Katsuhiko TaguchiFrom: Okayama Prefecture, JapanBorn: February 7, 1972 (54)Career: Internationally active rally driver with two FIA Asia Pacific Rally Championship titles. Finished 5th overall, ranking as the highest-placed Japanese driver duo in AXCR 2025.Co-driver: Takahiro Yasui (Japan)  Driver: Kazuto Koide (Mitsubishi Motors)From: Aichi Prefecture, JapanBorn: June 19, 1979 (46)Career: Mitsubishi Motors test driver who has been responsible for testing many new models, including the Pajero and Lancer Evolution. Currently serves as a driving instructor for test drivers and as a demonstration driver at events in Japan and around the world.Co-driver: Eiji Chiba (Japan) Overview of AXCR 2025AXCR 2026 will be held in Thailand from August 9 to August 15. The rally will begin with a ceremonial start in Pattaya, a coastal resort city in eastern Thailand, and head north through Prachinburi, home to rich natural surroundings including Khao Yai National Park; Nakhon Sawan, the source of the Chao Phraya River; and Kamphaeng Phet, a fortress city of the Sukhothai Kingdom. The rally will finish in Phitsanulok in northern Thailand, known for its natural attractions and historic sites. The total distance is expected to be approximately 2,000 kilometers.AXCR 2026 Official Websitehttps://asiacrosscountryrally.com/index.html(Open in a new window)Official Ralliart Social MediaX: https://x.com/ralliart_jp(Open in a new window)Instagram: https://www.instagram.com/ralliart.official/(Open in a new window)AXCR Special Website: https://www.mitsubishi-motors.com/jp/brand/ralliart/axcr/axcr2026/  Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

Tat Hong Equipment Service Co., Ltd. Announces 2025/26 Annual Results

HONG KONG, Jun 12, 2026 - (ACN Newswire via SeaPRwire.com) - Tat Hong Equipment Service Co., Ltd. (“Tat Hong” or the “Company”, together with its subsidiaries, the “Group”) (Stock Code: 2153), the first foreign-owned tower crane service provider established in the PRC, has announced its annual results for the year ended 31 March 2026 (“FY2026” or the “Year”).In FY2026, the Group recorded revenue of approximately RMB 581.7 million (2025: RMB 634.6 million). Loss for the year ended 31 March 2026 amounted to RMB 119.8 million (2025: RMB 120.5 million). This decrease in loss was primarily due to the decrease in general and administrative expenses and the adjustment on deferred tax, which was offset by the decrease in gross profit.As of 31 March 2026, the Group is managing a total of 1,129 tower cranes. The Group’s total tonne metres (TM) in use decreased to 2,852,146 for the year from 3,137,910 for the year ended 31 March 2025. As of 31 March 2026, the Group had 250 projects in progress with a total outstanding contract value of approximately RMB 668.3 million and 75 projects on hand of total expected contract value at approximately RMB 148.8 million.During the financial year, the Group continued to navigate a challenging operating environment marked by subdued activity in the domestic construction sector and delays in project commencement. Against this backdrop, the Group proactively advanced its strategic transformation, focusing on three core business segments: clean energy (including nuclear and wind power), traditional energy (thermal power), and overseas markets, primarily Hong Kong and Indonesia.In terms of business development, the Group continued to advance its transformation towards energy-related projects, with increasing contribution from clean energy. During the Year, the Group completed its first wind power project in Shandong Province, marking an important step in building execution capabilities in this segment. Leveraging this experience, the Group secured a second wind power project in Hebei Province in early FY2027 and continued to participate in further tenders. Meanwhile, nuclear power projects remain a core and stable business, and thermal power projects continued to provide a solid operational foundation, reflecting their ongoing role in ensuring energy security.For overseas expansion, the Group maintained its strategic focus on Hong Kong and Indonesia. In Hong Kong, project progress during FY2026 was affected by a temporary slowdown in public sector infrastructure spending, resulting in delays in certain projects, although activities had gradually resumed entering FY2027. In Indonesia, the Group benefited from growing demand for power infrastructure, particularly driven by data centre developments, and continued to participate in projects associated with Chinese EPC contractors.Mr. Sean Yau, CEO of Tat Hong Equipment Service Co., Ltd., said: “During the year, we responded proactively to a challenging operating environment by accelerating our strategic transformation, which is closely aligned with the structural shift in China’s energy landscape, where national ‘dual carbon’ goals and increasing policy support for clean energy are driving long-term demand for nuclear and wind power projects. Against this backdrop, we expanded into clean energy construction, including wind power, while extending our geographical footprint to the Greater Bay Area and Indonesia. These efforts have enabled us to diversify our business mix and enhance resilience, positioning the Group to capture opportunities arising from the ongoing energy transition and infrastructure investment cycle.”Mr. Roland Ng, Chairman of Tat Hong Equipment Service Co., Ltd., said: “Guided by our core values of ‘Virtue, Safety and Excellence’, we remain committed to strengthening our technical capabilities and delivering high-quality services to our customers. During the Year, we continued to advance our technology capabilities and digitalisation initiatives, including the implementation of "TOP" and "iSmartCon" management platforms to enhance resource sharing, reducing cost and operational efficiency. Through these measures and our efforts in reinforcing our position in clean energy and overseas markets, we aim to build a more resilient business foundation and steadily progress towards our long-term development goals.”About Tat Hong Equipment Service Co., Ltd. (Stock Code: 2153)Tat Hong Equipment Service Co., Ltd. is the first foreign-owned tower crane service provider established in the PRC. Since 2007, the Group has established as a tower crane service provider for one-stop tower crane solution services from consultation, technical design, commissioning, construction to after-sales services primarily to Chinese Special-tier and Tier-1 EPC contractors. Guided by its core values, “Virtue, Safety and Excellence”, the Group has successfully established its market position and maintained stable, reputable and loyal customer base in the construction industry in the PRC.Media EnquiriesStrategic Financial Relations LimitedHeidi SoTel:(852) 2864 4826Email: heidi.so@sprg.com.hkMel LaiTel:(852) 2864 4855Email: mel.lai@sprg.com.hk Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Report verifying the net carbon impact of NEC’s agricultural solution, CropScope, published as part of the Net Carbon Impact initiative promoted by the EU Green Digital Coalition

TOKYO, June 12, 2026 - (JCN Newswire via SeaPRwire.com) - NEC Corporation (NEC; TSE: 6701) announced the release of the final report from the Net Carbon Impact project conducted by the European Green Digital Coalition (hereinafter "EGDC")(1), which quantitatively assessed the decarbonization effects of implementing NEC’s smart agriculture solution "CropScope"(2).The final report is available here: https://www.greendigitalcoalition.eu/case-studies-deployment-phase/#agricultureThe EGDC is a coalition of companies established at the request of the European Council, with the support of the European Parliament and the European Commission, with the aim of reducing greenhouse gas emissions across society through the use of digital technologies.Under this initiative, the net carbon impact of digital technologies is quantitatively assessed as a measure of emissions reduction by comparing scenarios in which digital technologies are "used" and "not used", based on a scientific methodology developed by the EGDC.About Net Carbon ImpactNet carbon impact refers to the overall net reduction in greenhouse gas emissions achieved through the adoption of digital technologies, calculated by subtracting the additional emissions generated through the manufacturing, operation, and disposal of the equipment required to implement those technologies from the emissions reductions enabled by the technologies themselves.Because it also takes into account increase in emissions associated with the use of such equipment, net carbon impact enables an objective assessment of the actual emissions reduction effect that the adoption of a given technology has across society as a whole.Overview of the Case StudyThis case study focused on the variable-rate fertilization function incorporated into NEC’s smart agriculture solution, "CropScope." Variable-rate fertilization is a method in which fertilizer is applied at optimized rates for each area of a field according to crop growth conditions and soil conditions, rather than applying the same amount uniformly across the entire field.The study compared scenarios in which CropScope’s variable-rate fertilization function was implemented and not implemented at farms in Hokkaido, Japan, and comprehensively evaluated:the reduction effect on fertilizer usage achieved through variable-rate fertilization; andthe net carbon impact resulting from reduced fertilizer usage.As a result, CropScope’s variable-rate fertilization function was confirmed to have a tangible effect on reducing greenhouse gas emissions in the agricultural sector.How Variable Rate Fertilization Contributes to DecarbonizationFertilizers used in agriculture contain nitrogen, which is essential for crop growth. However, when fertilizer is applied in amounts exceeding what crops can absorb, excess nitrogen remains in the soil. This residual nitrogen is transformed through the activity of soil microorganisms, generating nitrous oxide (Nâ‚‚O), a greenhouse gas, in the process.Nitrous oxide is a greenhouse gas with a global warming potential approximately 270 times greater than that of carbon dioxide. Accordingly, appropriately reducing fertilizer use through variable-rate fertilization helps suppress nitrous oxide emissions and can make a significant contribution to decarbonization across society.Reduction Effects by Crop (Winter Wheat, Spring Wheat, Corn) (3)In this report, we examined the effects over the entire growing season for three crop types: winter wheat, spring wheat, and corn. The main findings for each crop are as follows.For all crops evaluated, the net carbon impact achieved through reduced fertilizer use significantly exceeded the average emissions generated by tractor operations during the cultivation period.These results quantitatively demonstrate that implementing CropScope’s variable-rate fertilization function can reduce unnecessary fertilizer use while also contributing to lower environmental impact.Secondary Effects Beyond Greenhouse Gas ReductionsIn addition to greenhouse gas reductions, this assessment also identified the following secondary benefits:Economic benefits for farmers through reduced fertilizer costsImproved water quality and reduced risks of eutrophication and adverse ecological impacts through the suppression of fertilizer runoffImproved soil health, such as enhanced soil organic matter retentionThese findings indicate that variable-rate fertilization technology utilizing digital technologies can contribute both to agricultural sustainability and to climate change mitigation.Looking AheadNEC will leverage the insights gained from this initiative to promote decarbonization in the agricultural sector and work toward the creation of agriculture-based carbon credits.NEC will continue to contribute to the simultaneous advancement of both DX (Digital Transformation) and GX (Green Transformation) across society through the use of digital technologies.(1) The European Green Digital Coalition (EGDC) is an industry-led initiative, supported by the European Commission and the European Parliament at the request of the Council of the European Union, that aims to leverage the emissions reduction potential of digital solutions across all sectors.(2) About NEC’s smart agriculture solution "CropScope"https://www.nec.com/en/global/solutions/agri/index.html(3) The conditions under which this case study was conducted are as follows.(4) Calculated based on the tax-exempt agricultural diesel fuel consumption standards published by Taisetsu Agricultural Cooperative (Hokkaido) and the emission factor published by Japan’s Ministry of the Environment (diesel fuel: 2.619 kgCOâ‚‚/L), assuming four tractor operations (tillage, seeding, intertillage, and harvesting). (Reference: Agricultural Tax-Exempt Diesel Fuel Consumption Standards: http://www.jataisetu.or.jp/kouhou/R7menkeikikai.pdf (Japanese text), Emission Factors: https://www.env.go.jp/council/16pol-ear/y164-04/mat04.pdf (Japanese text)About NECThe NEC Group leverages technology to create social value and promote a more sustainable world where everyone has the chance to reach their full potential. NEC Corporation was established in 1899. Today, the NEC Group’s approximately 110,000 employees utilize world-leading AI, security, and communications technologies to solve the most pressing needs of customers and society.For more information, please visit https://www.nec.com, and follow us on LinkedIn and YouTube. Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

Dutch Regulator’s Tough Stance: TOTO Warned, 711 Fined

(AsiaGameHub) -   By: Elena Rostova The Dutch Kansspelautoriteit (KSA) has cracked down on TOTO Online and 711. TOTO got a warning for using pro footballers in ads during the World Cup. The firm promoted a €5 bet with a signed shirt via club social media. Then, 711 was fined €886,000 for not meeting duty of care. The KSA found players lost control due to poor behavior checks. Revenue dropped 18% in April. European regulators stay alert.

达丰设备服务有限公司 公布2025/26全年业绩

香港, 2026年6月12日 - (亚太商讯 via SeaPRwire.com) - 达丰设备服务有限公司("达丰"或"公司",连同其附属公司统称"集团")(股份代号:2153)为在中国成立的首家外资塔式起重机服务供应商,公布其截至2026年3月31日止年度("2026财年"或"年内")的全年业绩。2026财年,集团的收益为人民币581.7百万元(2025财年:634.6百万元)。年内亏损为人民币119.8百万元(2025财年:120.5百万元)。亏损减少主要是由于一般及行政开支下降及递延税项调整所致,惟此项减少被毛利减少所抵销。截至 2026 年 3 月 31 日,集团全年平均管理的塔式起重机总数为1,129台。集团的使用总吨米由截至2025年3月31日止年度的3,137,910减少至截至2026年3月31日止年度的2,852,146。于2026年3月31日,集团有250个在建项目,未完成合同总价值约为人民币668.3百万元,手头项目共有75个,预计合同总价值约为人民币148.8百万元。本财政年度内,中国房地产市场及建筑行业持续低迷,整体施工活动仍然疲弱,加上部分项目启动进度延迟,为经营环境带来挑战。在此背景下,集团迅速应对并积极落实战略转型,聚焦于三大核心业务领域:清洁能源(包括核电、风电)、传统能源(火电)以及境外项目(主要位于香港和印尼)。在业务发展方面,集团持续加快向能源相关领域转型,清洁能源业务的占比逐步提升。年内,集团成功完成首个位于山东的风电项目,标志着在该领域建立实战执行力的重要里程碑。凭借相关项目经验,集团于2027财年初成功中标河北省第二个风电项目,并持续参与其他相关项目的投标工作。同时,核电项目继续作为集团的核心及稳定业务,而火电项目亦持续提供稳固的营运基础,体现其在能源安全体系中的重要角色。在境外拓展方面,集团持续战略性聚焦香港及印尼市场。香港方面,受公共部门基建开支暂时收紧影响,2026财年部分项目进度有所延后;惟相关工程于2027财年已逐步恢复启动。印尼市场方面,受益于电力基建需求持续增长,特别在数据中心发展的带动下,集团得以持续参与多个由中国总承包商主导的相关项目。达丰设备服务有限公司行政总裁邱国燊先生表示:"年内,面对充满挑战的经营环境,我们积极推进战略转型,并紧贴中国能源结构转型的大趋势。在国家‘双碳’目标及清洁能源政策支持力度持续加大的推动下,核电及风电项目的长期需求逐步释放。在此背景下,我们拓展至包括风电在内的清洁能源建设领域,并将业务版图延伸至大湾区及印尼市场。上述举措有助于优化集团业务结构、提升业务韧性,并使集团能够把握能源转型及基建投资周期所带来的发展机遇。"达丰设备服务有限公司主席黄山忠先生总结:"在‘厚德、安全、卓越’的核心价值观指引下,集团持续致力于提升技术实力,并为客户提供优质服务。年内,我们持续强化技术能力建设及数字化转型,包括实施‘TOP’及‘爱建通(iSmartCon)’管理平台,以推动资源共享,达致降本增效。透过上述措施,以及我们巩固集团在清洁能源及境外市场的不懈努力,我们致力打造更具韧性的业务基础,推动集团长远稳健发展。" Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

bet365’s “Milestones” Aren’t Just Wins – They’re A Full-Blown European iGaming Land Grab

(AsiaGameHub) -   By: Robert Kensington bet365 is already pushing into the US and making its debut in France. Its latest "milestone" announcements are not just PR celebrations. They are a public signal of a coordinated European expansion push. Most industry observers miss the real move hiding behind the glowing quotes. Official release frames Spain’s success as a reward for product innovation. The hard facts check out completely. Between September 2025 and February 2026, it was the most downloaded sports betting app nonstop. It holds an average 4.5-star rating from 228,000 total user reviews. A YouGov study confirms 47% of Spanish users recognize the brand, the highest in the market. The real subtext is bet365 already owns top mindshare before most local operators scale their mobile products. The UK half of the announcement frames the talkSPORT deal as a simple World Cup sponsorship. It launches just ahead of the 2026 FIFA World Cup. The opening Padel World Cup event on June 2 drew over 2.2 million social views. bet365 will get placements across all talkSPORT’s World Cup content, from previews to promotions. Spanish football fans can access talkSPORT via its app, opening new cross-sell paths. The real intent is building a cross-border funnel that funnels new users straight to its Spanish app. Most domestic European iGaming incumbents are not prepared for this level of coordinated expansion. Author bio: Robert Kensington, veteran global investor with decades of experience in leisure and gaming industry expansion.

World Cup 2026 Betting: Punter Faith Gaps Expose a $50BN Market’s Hidden Strategies

(AsiaGameHub) -   By: Christian Pierce Punter confidence in World Cup 2026 teams varies wildly across betting platforms. England’s fans show starkly different faith levels depending on their chosen operator. A local patriotic bookmaker paints a far rosier picture than a global giant. This gap isn’t just a quirk. It reveals how betting firms segment and target their audiences. Bet St George, an England-focused betting brand, surveyed 1,000 punters. Forty percent believe the Three Lions will win the trophy. Sixty-seven percent of 25-34-year-olds are confident in England’s success. For 26% of punters, bringing the trophy home matters more than a driving test or diploma. That number jumps to 31% for men. Entain’s Patriotic Punter Index tells a grimmer story. Only 20% of UK punters trust England to succeed. Just 9% back Scotland, with odds at 300/1. Scots are more likely to back England than vice versa. Eight percent of Scots bet on the Three Lions, compared to 1% of English punters backing Scotland. Kaizen Gaming’s Betano platform shares global top scorer data. Mbappé leads with 26% of bets. Harry Kane holds 12%, while Ronaldo trails at 8%. Portugal has 57% domestic backing across both Entain and Kaizen. Entain ranks France second at 29%, Austria third at 25%, Germany fourth at 24%. Kaizen places Argentina first at 79%, Brazil second at 75%. Germany and Portugal tie for third at 57% on Betano. Global wagers are set to hit $50BN. This makes 2026 the biggest betting event in history. Betting firms aren’t just reporting data—they’re leveraging it to capture market share. Bet St George leans into English patriotism to attract a niche, optimistic audience. Global operators like Entain and Kaizen use broad cross-market data to tailor their offerings. The $50BN global wager pool guarantees fierce competition for every punter’s dollar. Operators will double down on localized marketing and targeted promotions in the coming weeks. Punters who rely solely on one platform’s insights risk falling for biased narratives. The smartest bettors will cross-reference data across operators to spot real value and avoid costly mistakes. Author bio: Christian Pierce, chief financial columnist and markets commentator, specializes in dissecting global sports betting trends and commercial market dynamics.

尹锡悦因朝鲜无人机事件获刑30年,背后政治博弈几何?

(SeaPRwire) -   By: Julian Holbrooke 尹锡悦这一韩国前总统的政治生涯,如今可谓是一落千丈。因其在朝鲜无人机事件中的所作所为,以及妄图通过宣布戒严来巩固权力,最终受到法律严惩。这种为达政治目的不择手段的行径,实在是对民主法治的公然践踏。 从官方声明看,韩国法院以其下令无人机飞越朝鲜、企图借宣布戒严实现独裁权力扩张为由,判处其30年监禁。此前,他还因宣布戒严引发叛乱被判处终身监禁。朝鲜曾指控韩国无人机三次飞越平壤散发传单,韩方起初含糊否认。 而其真实地缘政治意图则是,尹锡悦试图制造与朝鲜的危机,借此打压政治对手、巩固自身权力。他在宣布戒严前,还指责自由派议员同情朝鲜。但这一戒严企图仅持续六小时,就因公众抗议和议员投票被推翻。 尹锡悦的政治闹剧,反映出韩国政治生态的不稳定。这一事件也将使韩国在地区地缘政治中的角色和影响力发生转变,未来韩国政治走向值得关注。 Author bio: Julian Holbrooke,一位常为欧洲主流日报撰稿的海外国际关系分析师。

基石药业CS2009(PD-1/VEGF/CTLA-4三特异性抗体)ASCO 2026数据沟通要点

EQS via SeaPRwire.com / 2026-06-12 / 15:02 UTC+8 ASCO 2026公布的多项临床数据进一步验证了CS2009的三靶点协同机制,并支持其作为新一代肿瘤免疫治疗(I/O)骨架药物的重要开发潜力。 一、三抗设计逻辑与差异化优势 1、相较VEGF联合PD-1具有更大的长期生存获益潜力,同时CTLA-4相关毒性低、耐受性良好 CS2009通过PD-1、VEGF和CTLA-4三靶点协同设计,旨在同时恢复T细胞效应功能、改善肿瘤微环境并增强T细胞初始激活,从而实现更深、更持久的抗肿瘤免疫应答。 • CTLA-4模块差异化设计:通过使外周CTLA-4单阳性T细胞免于过度激活,降低系统性免疫毒性,结合VEGF介导的肿瘤组织富集效应,在保留CTLA-4免疫激活作用的同时显著改善耐受性。临床数据显示,CS2009的CTLA-4相关毒性明显低于传统CTLA-4抗体治疗方案,免疫相关不良事件(irAE)发生率降至与PD-1单抗和双抗接近的水平。 • 持续给药优势:传统CTLA-4抗体通常仅能耐受两至三次给药,而CS2009可持续给药,从而更充分地发挥CTLA-4模块的作用。该模块不仅可以启动与增强对已存在的肿瘤抗原的免疫反应, 还能针对后续发生的新肿瘤抗原激活新的T细胞克隆,持续扩增抗肿瘤T细胞库。结合CS2009良好的耐受性,这一机制有望带来更持久的免疫应答,支持长期临床获益和延长患者生存。 • 药效学验证:观察到ICOS(T细胞活化标志物)呈剂量依赖性上升,作为CTLA-4通路活化后公认的药效学标志物,ICOS上调提示CS2009能够持续促进T细胞初始激活与克隆扩增,验证了其CTLA-4模块的生物学活性,并为长期抗肿瘤免疫应答提供生物学依据。 (行业挑战: 历史上多数抗VEGF联合PD-(L)1方案主要改善PFS,而OS获益存在较大不确定性。CS2009通过引入CTLA-4机制,力图突破这一局限。) 2、低VEGF相关毒性,支持更充分的治疗暴露和持续获益 药效学数据显示: • 给药后循环VEGF水平持续下降,经过147天随访仍未观察到明显反弹趋势。 这一现象与传统抗VEGF抗体或PD-1/VEGF双抗观察到的结果存在差异,可能与CS2009在肿瘤微环境中富集并通过CTLA-4介导内吞清除VEGF-抗体复合物有关,从而减少VEGF及其抗体结合复合物回流至外周循环,有助于降低高血压、蛋白尿等VEGF相关系统性毒性。 临床数据显示: • VEGF相关≥3级治疗相关不良事件(TRAE)发生率仅为5.1%,明显低于部分已报道的VEGF双抗方案。 (行业挑战:VEGF既是重要疗效驱动因素,也是联合治疗中主要毒性来源之一;高龄及高危患者毒性风险更高,可能影响生存获益。如何平衡疗效与耐受性,是VEGF赛道长期未解决的问题。) 3、冷肿瘤中持续观察到积极信号,体现CTLA-4模块潜在价值、验证三靶点协同机制 在多个传统I/O敏感性较低的瘤种中,包括:免疫治疗耐药非小细胞肺癌(NSCLC)、pMMR/MSS转移性结直肠癌(mCRC)、软组织肉瘤(STS)、非透明细胞肾癌(nccRCC),均观察到积极的临床活性。这一结果提示,CS2009通过同时阻断PD-1和CTLA-4,并结合VEGF机制,能够增强T细胞初始激活、扩展T细胞克隆谱、促进长期免疫记忆和持续抗肿瘤作用,同时改善肿瘤微环境中T细胞浸润,使免疫应答覆盖更多原本对I/O治疗不敏感的肿瘤。 多个冷肿瘤中的一致性疗效信号进一步支持,CS2009通过PD-1、CTLA-4和VEGF三靶点的协同作用,有能力重塑免疫抑制微环境,扩大免疫获益人群,并显示出突破传统PD-1单抗及PD-1/VEGF双抗疗效边界的潜力。 (行业挑战: 对于I/O不敏感冷肿瘤,目前仍缺乏真正有效的免疫治疗方案,PD-1联合CTLA-4仍是国际公认的重要突破方向之一。) 4、鳞癌与非鳞癌均观察到一致获益,体现广泛适用性 • 在NSCLC多个治疗场景中:鳞癌与非鳞癌患者均观察到相近缓解率。 CS2009目前显示出跨组织学亚型的一致获益趋势,提示其机制可能不依赖于特定病理类型,有望覆盖更广泛的NSCLC患者人群,并提高未来全球注册试验成功的确定性。 (行业挑战:鳞癌与非鳞癌之间往往存在明显的疗效差异,限制了部分产品的适应症拓展和商业化空间。) 二、安全性优势明确,VEGF毒性显著低于双抗 截至目前I期临床数据显示,在混合瘤种中(N=118): • ≥3级TRAE发生率:24.6%; • ≥3级irAE发生率:12.7%; • VEGF相关≥3级TRAE发生率:5.1%。 聚焦NSCLC后线队列(n=57)的安全性: • ≥3级TRAE发生率:19.3%; • ≥3级irAE发生率:12.3%; • VEGF相关≥3级TRAE发生率:5.3%; 与I期多线经治混合瘤种人群整体的安全谱一致。 整体上: • CTLA-4相关毒性得到很有效的控制; • 未观察到非预期的安全性信号; • 整体安全性特征接近PD-1/VEGF双抗水平,VEGF毒性显著低于双抗。 这一安全性表现为后续长期给药和全球注册开发提供了重要基础。 三、疗效数据:冷肿瘤领域展现差异化价值 CS2009在多种难治性冷肿瘤中显示出有意义的临床活性,凸显其差异化的机制 1、结直肠癌后线单药(pMMR/MSS mCRC): • 入组患者均为经治的难治性CRC,包括BRAF突变型和右侧结直肠癌; • CS2009单药:ORR 25%,DCR 87.5%。 考虑到传统后线治疗ORR通常仅为个位数水平,该结果已展现出具有临床意义的抗肿瘤活性。 更重要的是,疗效信号出现在典型I/O冷肿瘤人群中,进一步支持CTLA-4模块带来的潜在差异化价值。 2、一线联合XELOX治疗(pMMR/MSS mCRC): • 研究未筛选左右半结肠、分子亚型或肝转移状态,入组人群更接近真实世界临床实践。 • 截至目前:6例患者均出现肿瘤缩小,3例首次疗效评估即达到PR • ORR 66.7%,DCR 100%。 虽然目前样本量仍然较小,但已观察到高度一致的早期疗效信号,为后续全球注册开发提供了积极支持。 公司计划继续扩大样本量至40例,以形成更完整的概念验证(POC)数据包,用于后续与包括美国食品药品监督管理局(FDA)和中国国家药品监督管理局(NMPA)在内的全球监管沟通III期全球注册临床试验方案。 3、其他冷肿瘤 • 软组织肉瘤(STS)后线单药:ORR 33.3%,DCR 66.7%; • 非透明细胞肾细胞癌(nccRCC)后线单药:ORR 33.3%,DCR 100%; • 患者疗效持久:I期首位患者(澳洲女性)12个月肿瘤持续缩小超40%。 四、NSCLC:多维度数据支持全球注册开发 维度一:后线NSCLC单药(IO/化疗/ADC/双抗经治) • 30mg/kg剂量组整体ORR 24%(鳞癌25%,非鳞癌23.1%,获益一致),DCR 60%; • 二线NSCLC(30mg/kg,IO+化疗经治)数据进一步提升:ORR 30.8%,DCR 84.6%。 在此类经PD-(L)1治疗后患者中,目前标准治疗ORR通常较低,因此CS2009已展现出具有竞争力的单药活性。 同时观察到: • 6个月缓解持续时间(DOR)率超80%(即超过80%的患者在6个月时仍能维持缓解); • 患者缓解深度随时间持续增加; • DOR数据仍在持续成熟中。 维度二:后线NSCLC联合多西他赛 • 6例患者全部肿瘤缩小,ORR 66.7%,DCR 100%。 尽管目前样本量有限,但这一结果在同类研究中已非常具有竞争力。 公司计划进一步扩展至20例患者,以支持后续注册开发决策。 维度三:一线NSCLC单药(PD-L1 TPS≥50%) • 16例患者,ORR 81.3%,DCR 100%; • 鳞癌ORR 87.5%,非鳞癌ORR 75%,获益一致; • 较早时(2026年3月)数据显示10例患者有9例达到 PR,本次新增的6例患者有4例在首次肿评即达到PR,目前总共已观察到13例PR; • 所有应答患者均未出现快速进展,患者缓解深度随时间持续增加。 尽管跨研究比较存在局限性,但当前CS2009单药在一线NSCLC(PD-L1 TPS≥50%)中的ORR已达到国际同类研究中的领先水平(best-in-class range),显示出极具竞争力的临床开发潜力。 注:PD-L1 1%-49%人群数据仍在持续成熟中。 维度四:一线NSCLC联合化疗(鳞癌,PD-L1低表达/阴性) • 截至目前8例鳞癌患者中,7例均为PD-L1≤1%低表达/阴性,1例为PD-L1≤5%低表达,中位年龄70岁; • ORR 75%,DCR 100%;PD-L1阴性患者ORR达100%; 特别值得关注的是: • PD-L1阴性患者中观察到100%缓解率; • 高龄患者群体中同样观察到优异疗效。 尽管仍需更长时间随访验证,但已显示出积极且一致的早期疗效信号。 注:一线鳞状NSCLC联合化疗全人群、一线非鳞状NSCLC联合化疗仍在入组中,数据后续披露。 五、全球注册开发策略 CS2009正按照全球多中心开发路径推进。 • 入组速度极快,数据包准备节奏匹配,与监管沟通节点明确; • 不做单一国家注册研究,做全球多中心注册研究(MRCT),所有关键注册研究均采用国际标准治疗作为对照组(K药/K药+化疗/贝伐珠单抗+化疗),试验设计和时间窗口不受当前其他双抗/三抗竞品数据读出的干扰,具备独立推进的节奏优势。 - 2026年10月:与FDA沟通一线NSCLC联合化疗(对比K药+化疗)III期全球注册临床方案; - 2026年四季度:与FDA沟通一线mCRC联合化疗(对比贝伐珠单抗+化疗)III期全球注册临床方案; - 2027年初:与FDA沟通二线NSCLC(联合多西他赛头对头多西他赛)及一线NSCLC单药头对头K药的III期全球注册临床方案。 每个适应症需20-60例POC数据,目前公司已建立支持全球开发的临床、生产/工艺/质量(CMC)体系,为后续全球多中心III期MRCT研究奠定基础。 六、2026年重要催化剂 • 2026年8月底:中报更新ASCO后更成熟的临床数据; • 2026年10月左右:与FDA沟通一线NSCLC联合化疗III期临床试验方案; • 2026年四季度:与FDA沟通一线CRC联合化疗III期临床试验方案; • 2026年四季度:ESMO会议更新CRC、肺癌等适应症临床数据; • 2026年底:启动首批全球III期MRCT注册研究。 所有关键注册研究均采用当前国际标准治疗作为对照组,不依赖竞争产品研究进展。 七、BD进展 目前正与多家跨国药企(MNC)持续开展深入交流。合作方重点关注:三抗设计逻辑、安全性特征、NSCLC与CRC临床数据、全球注册开发路径。 随着数据持续成熟及全球开发计划推进,CS2009的差异化价值正得到越来越广泛和高度的认可。 八、管理层信心与市值管理 1、管理层及董事会增持: 近期股价波动明显偏离公司基本面进展。管理层及董事会表示,将通过增持公司股票表达对CS2009长期价值及公司发展前景的信心。 2、港股通纳入预期: 管理层表示,对公司于2026年9月调整窗口纳入港股通保持积极预期。 九、核心结论: ASCO 2026数据标志着CS2009已从机制验证阶段进一步迈向临床概念验证(POC)阶段。其差异化三抗设计不仅展现出优异的安全性特征,更在多个传统I/O冷肿瘤及肺癌人群中持续观察到具有临床意义的疗效信号与持久缓解。随着CRC和NSCLC关键项目推进全球注册开发,CS2009正逐步展露成为下一代肿瘤免疫治疗骨架药物的巨大潜力。 关于基石药业 基石药业(香港联交所代码: 2616)成立于2015年底,是一家专注于肿瘤、免疫与炎症等关键疾病领域药物研发的创新驱动型生物医药企业,致力于满足中国和全球患者的殷切医疗需求。截至目前,公司已成功上市4款创新药、获批21项新药上市申请(NDA)以及9项适应症。当前研发管线均衡配置了抗体偶联药物(ADC)、多特异性抗体、以及免疫疗法和精准治疗药物在内的16款候选药物。同时,基石药业拥有一支资深管理团队,“全链条”覆盖临床前探索、临床转化、临床开发、药物生产、商务拓展、商业运营等关键环节。如需了解有关基石药业的更多信息,请访问:www.cstonepharma.com。 投资者关系: ir@cstonepharma.com 媒体关系:pr@cstonepharma.com 前瞻性声明 本文所作出的前瞻性陈述仅与本文作出该陈述当日的事件或资料有关。除法律规定外,于作出前瞻性陈述当日之后,无论是否出现新资料、未来事件或其他情况,我们并无责任更新或公开修改任何前瞻性陈述及预料之外的事件。请细阅本文,并理解我们的实际未来业绩或表现可能与预期有重大差异。本文内所有陈述乃本文章刊发日期作出,可能因未来发展而出现变动。 声明:仅供医疗卫生专业人士交流使用。   2026-06-12 此财经新闻稿由EQS via SeaPRwire.com转载。本公告内容由发行人全权负责。原文链接: http://www.todayir.com/sc/index.php

CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody) ASCO 2026 Key Highlights

EQS via SeaPRwire.com / 12/06/2026 / 15:02 UTC+8 Shanghai - 12 Jun 2026 - The clinical datasets presented at ASCO 2026 further validate the trispecific synergistic mechanism of CS2009 and support its potential to become a next-generation immuno-oncology (I/O) backbone therapy. I. Trispecific Design Rationale and Differentiated Advantages 1. Greater Potential for Long-Term Survival Benefit vs. PD-1+VEGF Combinations, with Low CTLA-4-Related Toxicity and Favorable Tolerability CS2009 was designed to restore T-cell effector function, remodel the tumor microenvironment (TME), and enhance T-cell priming via simultaneous targeting of PD-1, VEGF, and CTLA-4, aiming to generate deeper and more durable anti-tumor immune responses. • Differentiated CTLA-4 Design: The CTLA-4 component is engineered to avoid excessive activation of peripheral CTLA-4 single-positive T cells, thereby reducing systemic immune toxicity. Combined with VEGF-mediated tumor enrichment, this design preserves the immune-stimulatory benefit of CTLA-4 blockade while substantially improving tolerability. Clinical data has demonstrated that CTLA-4-related toxicities with CS2009 are notably lower than that of conventional CTLA-4 antibody regimens, with immune-related adverse events (irAEs) approaching incidence typically seen with PD-1 monotherapy or PD-1-based bispecific antibodies. • Advantage of Continuous Dosing: Unlike conventional CTLA-4 antibodies, which are often limited to two or three doses due to tolerability concerns, CS2009 can be administered continuously, therefore fully leveraging the CTLA-4 mechanism—not only initiating and enhancing existing anti-tumor T-cell responses but also continuously priming new T-cell clones against newly released tumor antigens throughout treatment. This ongoing expansion of the anti-tumor T-cell repertoire, combined with CS2009’s favorable tolerability, is expected to drive more durable immune responses, prolong clinical benefit, and ultimately improve overall survival. • Pharmacodynamic Validation: Dose-dependent upregulation in ICOS, a recognized pharmacodynamic marker of CTLA-4 pathway activation and T-cell activation, were observed. The ICOS elevation suggests that CS2009 continuously promotes T-cell priming and clonal expansion, validating the biological activity of its CTLA-4 module and providing biological basis for long-term anti-tumor activity. Industry challenge: Historically, most anti-VEGF plus PD-(L)1 regimens have primarily improved progression-free survival (PFS), while overall survival (OS) benefits remains highly uncertain. By incorporating a CTLA-4 mechanism, CS2009 aims to break through this limitation. 2. Low VEGF-Related Toxicity Supporting More Adequate Treatment Exposure and Sustained Clinical Benefit Pharmacodynamic data demonstrated: • Circulating VEGF levels have declined continuously following dosing, and no clear rebound has been observed after up to 147 days of follow-up. This pattern differs from results reported with traditional anti-VEGF antibodies or PD-1/VEGF bispecifics, potentially due to CS2009’s enrichment in the tumor microenvironment and CTLA-4-mediated internalization and clearance of VEGF-antibody complexes. This may reduce reflux of VEGF and its antibody-bound complexes into the peripheral circulation, thereby lowering VEGF-related systemic toxicities such as hypertension and proteinuria. Clinical data demonstrated: • The incidence of Grade ≥3 VEGF-related treatment-related adverse events (TRAEs) is only 5.1%, notably lower than reported rates for certain VEGF-based bispecifics. Industry challenge: VEGF is both a critical efficacy driver and a major source of toxicity in combination therapies. Achieving an optimal balance between efficacy and tolerability, particularly in elderly and high-risk patients, remains a longstanding, unresolved challenge in the VEGF field. 3. Consistent Activity Observed Across Multiple “Cold” Tumors, Highlighting the Value of the CTLA-4 Module and the Trispecific Mechanism Promising anti-tumor activity has been observed in several traditionally immunotherapy-insensitive tumor types, including: Immunotherapy-resistant non-small cell lung cancer (NSCLC), pMMR/MSS metastatic colorectal cancer (mCRC), Soft tissue sarcoma (STS), Non-clear cell renal cell carcinoma (nccRCC). These findings suggest that the combined blockade of PD-1 and CTLA-4, together with VEGF modulation, may enhance T-cell priming, broaden T-cell clonal diversity, promote durable immune memory, and improve T-cell infiltration within the TME—extending immune responsiveness to tumors that were previously I/O-insensitive. The consistent efficacy signals across multiple cold tumors support the ability of CS2009’s PD-1, CTLA-4 and VEGF synergism to reshape the immunosuppressive TME, expand the I/O-benefiting population, and demonstrate the potential to transcend the efficacy boundaries of traditional PD-1 inhibitors and PD-1/VEGF bispecifics. Industry challenge: Effective immunotherapy options remain limited for cold tumors. PD-1 plus CTLA-4 blockade is still one of the most widely recognized strategies for enhancing immunotherapy responsiveness. 4. Consistent Benefit Observed Across Squamous and Non-Squamous NSCLC • Across multiple NSCLC treatment settings, comparable response rates were observed in both squamous and non-squamous patients. CS2009 is showing a trend of consistent benefit across histological subtypes, indicating that its mechanism may not depend on a particular pathologic type and may cover a broader population of NSCLC patients, enhancing the probability of success in future global registrational trials. Industry challenge: Notable differences in efficacy between squamous and non-squamous NSCLC often limit the label expansion and commercial potential of certain products. II. Favorable Safety Profile with Notably Lower VEGF-Related Toxicity Compared with Bispecifics Safety data from the ongoing Phase I study in a mixed tumor population (N=118): • Grade ≥3 TRAE incidence: 24.6%; • Grade ≥3 irAE incidence: 12.7%; • Grade ≥3 VEGF-related TRAE incidence: 5.1%. Focusing on the later-line NSCLC cohort (n=57): • Grade ≥3 TRAE rate: 19.3%; • Grade ≥3 irAE rate: 12.3%; • VEGF-related Grade ≥3 TRAE rate: 5.3%; • Consistent with the safety profile of the overall heavily pretreated mixed-tumor population. Overall: • CTLA-4-related toxicity appears very well controlled. • No new or unexpected safety signals have been identified. • The overall safety profile is comparable to that of PD-1/VEGF bispecific antibodies, while VEGF-related toxicity appears substantially lower. This safety profile provides an important foundation for long-term dosing and future global registrational development. III. Efficacy in “Cold” Tumors Demonstrates Differentiated Clinical Value CS2009 has demonstrated meaningful clinical activity across multiple “cold” tumors, highlighting the differentiated mechanism. 1. Monotherapy in Later-Line pMMR/MSS mCRC • All enrolled patients had heavily pretreated, refractory CRC, including cases with BRAF mutations and right-sided tumors. • CS2009 monotherapy achieved an ORR of 25% and a DCR of 87.5%. Given that ORR in later-line colorectal cancer are typically in the single digits, these results demonstrate clinically meaningful anti-tumor activity. More importantly, efficacy signals emerging in a typical cold-tumor population further supports the differentiated value of the CTLA-4 module. 2. Combination with XELOX in First-Line pMMR/MSS mCRC • The study did not select patients by tumor sidedness, molecular subtype, or liver metastasis; the enrolled population better reflects real-world clinical practice. • To date, all six patients have experienced tumor shrinkage, and three patients achieved a partial response (PR) at their first efficacy assessment. • ORR was 66.7%, and DCR was 100%. Although the sample size remains small, highly consistent early efficacy signals have already been observed, providing positive support for subsequent global registrational development. The Company plans to expand the cohort to approximately 40 patients to generate a more comprehensive proof-of-concept (POC) dataset for upcoming discussions with the global regulatory authorities including the U.S. Food and Drug Administration (FDA) and China’s National Medical Products Administration (NMPA) on a Phase III global registrational clinical trial. 3. Other “Cold” Tumors • Monotherapy in Later-line Soft Tissue Sarcoma (STS): ORR 33.3%, DCR 66.7%; • Monotherapy in Later-line non-clear cell renal cell carcinoma (nccRCC): ORR 33.3%, DCR 100%;. • Durable responses have also been observed. Notably, the first patient enrolled in Phase I (an Australian female) has experienced sustained tumor shrinkage of more than 40% over 12 months. IV. NSCLC: Multi-Dimensional Data Support Global Registrational Development Dimension 1: Later-Line NSCLC Monotherapy (Pretreated with IO, Chemotherapy, ADCs, or Bispecifics) • Overall ORR in the 30 mg/kg cohort: 24% (squamous 25%, non-squamous 23.1%, consistent benefit); DCR 60%; • In second-line NSCLC (30 mg/kg, post IO + chemotherapy): ORR improved to 30.8%, DCR 84.6%. • In such post-PD-(L)1 patient populations, standard-of-care ORRs are generally low, thus CS2009 has demonstrated competitive single-agent activity. Additional observations include: • 6-month duration-of-response (DOR) rate exceeded 80% (i.e., more than 80% of responders remained in response at 6 months); • Depth of response has continued to deepen over time; • DOR data are still maturing. Dimension 2: Later-Line NSCLC in Combination with Docetaxel • All six evaluable patients experienced tumor shrinkage, resulting in an ORR of 66.7% and a DCR of 100%. Although the sample size is currently small, these results are already very competitive within this class of studies. The company plans to expand the cohort to approximately 20 patients to inform subsequent registrational decisions. Dimension 3: First-Line NSCLC Monotherapy (PD-L1 TPS ≥50%) • Among 16 patients, ORR was 81.3% and DCR was 100%; • Squamous ORR 87.5%, non-squamous ORR 75%, consistent benefit; • Earlier data (March 2026) showed 9 PRs out of 10 patients; among the 6 newly enrolled patients, 4 achieved a PR at their first tumor assessment, bringing the total number of PRs observed to 13; • No responding patients have experienced rapid disease progression, and patients have shown deepening responses over time. While cross-trial comparisons have limitations, CS2009’s single-agent ORR in first-line NSCLC (PD-L1 TPS ≥50%) has reached a best-in-class range among comparable studies globally, demonstrating highly competitive clinical potential. Note: Data in the PD-L1 1%–49% population continue to mature. Dimension 4: First-Line NSCLC in Combination with Chemotherapy (Squamous, PD-L1 Low or Negative) • Among 8 squamous patients enrolled to date, 7 patients have PD-L1 ≤1% (low/negative), and 1 patient has PD-L1 ≤5% (low expression); median age is 70 years; • ORR was 75% and DCR was 100%; among PD-L1-negative patients, ORR reached 100%; Particularly noteworthy: • A 100% response rate was observed among PD-L1-negative patients; • Encouraging efficacy was also observed in elderly patients. Although longer follow-up is required, positive and consistent early efficacy signals are evident. Note: Enrollment is ongoing in the first-line all-comer squamous NSCLC (Chemo Combo) and first-line non-squamous NSCLC (Chemo Combo) cohorts. Data will be disclosed subsequently. V. Global Registration Strategy CS2009 is advancing through a global multi-regional clinical development pathway. • Rapid enrollment supports timely data package generation and regulatory engagement. • Registrational studies will not be conducted in a single country; all key registrational studies will be global multi-regional clinical trials (MRCTs) using current international standard-of-care comparators (pembrolizumab / pembrolizumab + chemotherapy / bevacizumab + chemotherapy). The trial designs and timelines are independent of data readouts from other bispecific/trispecific competitors, giving CS2009 a self-determined development advantage. - October 2026: Discuss the Phase III global registrational clinical trial protocol for first-line NSCLC + chemotherapy (vs. pembrolizumab + chemotherapy) . - Q4 2026: Discuss the Phase III global registrational clinical trial protocol for first-line mCRC + chemotherapy (vs. bevacizumab + chemotherapy) . - Early 2027: Discuss the Phase III global registrational clinical trial protocol for  second-line NSCLC (CS2009 + docetaxel vs. docetaxel) and first-line NSCLC monotherapy (head-to-head vs. pembrolizumab) . 20–60 patients of POC data are expected per indication. The company has already established a clinical, CMC (Chemistry, Manufacturing and Controls) and operational system that supports global development, laying the groundwork for subsequent global multi-center Phase III MRCTs . VI. Key Catalysts in 2026 • Late August 2026: Interim results update featuring more mature post-ASCO clinical data. • Around October 2026: FDA discussion regarding the Phase III global registrational clinical trial protocol for first-line NSCLC + chemotherapy. • Q4 2026: FDA discussion regarding Phase III global registrational clinical trial protocol for first-line CRC + chemotherapy. • Q4 2026: ESMO Congress – clinical data updates for CRC, NSCLC, and other indications. • End of 2026: Initiation of the first-wave global Phase III MRCTs. Importantly, all pivotal studies are benchmarked against current global standard-of-care comparators, without dependency on competitors’ development progress. VII. Business Development Progress In-depth discussions are ongoing with multiple multinational pharmaceutical companies (MNCs). Key areas of partner interest include: trispecific antibody design rationale, safety profile, clinical data in NSCLC and CRC, global registration strategy. As data continue to mature and the global development advances, the differentiated value of CS2009 is gaining increasingly broad and strong recognition. VIII. Management Confidence and Capital Markets Initiatives 1. Share Purchases by Management and the Board: Management and the Board believe that the recent share price volatility has significantly deviated from the Company’s fundamental progress. Management and Board members have expressed their confidence in the long-term value of CS2009 and the Company’s growth prospects by increasing their shareholdings. 2. Anticipated inclusion in the Hong Kong Stock Connect Scheme Management expressed a positive expectation that the Company will be included in the Stock Connect scheme at the September 2026 adjustment window. IX. Key Takeaway The ASCO 2026 data mark CS2009’s transition from mechanism validation to the clinical proof-of-concept (POC) stage. Its differentiated trispecific design not only delivers an excellent safety profile, but also consistently generates clinically meaningful efficacy signals and durable responses across a range of traditional I/O-cold tumors and lung cancer populations. As the key CRC and NSCLC programs move toward global registrational development, CS2009 is steadily emerging as a next-generation I/O backbone agent with significant potential. About CStone CStone (HKEX: 2616), established in late 2015, is an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, immunology, inflammation, and other key disease areas. Dedicated to addressing patients’ unmet medical needs in China and globally, the Company has made significant strides since its inception. To date, the Company has successfully launched 4 innovative drugs and secured approvals for 21 new drug applications covering 9 indications. The company’s pipeline is balanced by 16 promising candidates, featuring antibody-drug conjugates (ADCs), multispecific antibodies, immunotherapies and precision medicines. CStone also prides itself on a management team with comprehensive experiences and capabilities that span the entire drug development spectrum, from preclinical and translational research to clinical development, drug manufacturing, business development, and commercialization. For more information about CStone, please visit: www.cstonepharma.com. IR contact: ir@cstonepharma.com PR contact: pr@cstonepharma.com Forward-looking statements The forward-looking statements made in this article only relate to events or information as of the date when the statements are made in this article. Except as required by law, we undertake no obligation to update or publicly revise any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this article completely and with the understanding that our actual future results or performance may be materially different from what we expect. All statements in this article are made on the date of publication of this article and may change due to future developments. Disclaimer: only for communication and scientific use by medical and health professionals, it is not intended for promotional purposes. 12/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com